A dose-escalating pilot study (NCT03017404) of pegylated liposomal Doxorubicin and Cyclophosphamide, followed by Docetaxel administration as a neoadjuvant chemotherapy regimen in patients with locally advanced breast cancer - Cheng, M; Song, Z; Qi, Y (Oncol Res Treat, 2019)
doi:10.1159/000498993